Premium
Hypopharyngeal Cancer Patient Care Evaluation
Author(s) -
Hoffman Henry T.,
Karnell Lucy H.,
Shah Jatin P.,
Ariyan Stephan,
Brown G. Stephen,
Fee Willard E.,
Glass Andrew G.,
Goepfert Helmuth,
Ossoff Robert H.,
Fremgen Amy M.
Publication year - 1997
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1097/00005537-199708000-00001
Subject(s) - medicine , hypopharyngeal cancer , stage (stratigraphy) , cancer , demographics , disease , cancer stage , medical record , clinical trial , medical care , surgery , general surgery , emergency medicine , demography , paleontology , sociology , biology
A survey was conducted to identify demographics and standards of care for treatment of hypopharyngeal squamous cell carcinoma in the United States. Data were accrued from voluntary submission of cancer registry and medical chart information from 769 hospitals representing 2939 cases diagnosed from 1980 to 1985 and 1990 to 1992. Clinical findings, diagnostic procedures employed, treatment practices, and outcome are presented. Overall, 5‐year disease‐specific survival was 33.4%, which segregated to 63.1% (stage I), 57.5%(stage II), 41.8% (stage III), and 22% (stage IV). Survival was best for patients treated with surgery only (50.4%), similar with combined surgery and irradiation (48%), and worse with irradiation only (25.8%). This analysis provides a standard to which current treatment practice and future clinical trials may be compared.